semaglutide and liver function targets MASH molecular pathways beyond weight loss Pharmacotherapy for Non-alcoholic Fatty Liver

Like all medicines, it can cause side effects

This effect is crucial for sustainable weight loss and long-term health outcomes

Funding The work was supported by research grants from the Novo Nordisk Foundation (grant no

A. V. Arutjunyan, I. G. Popovich, L. S. Kozina, and G. A. Ryzhak, Peptide Regulation of Ageing: From Experiment to Practice, Bentham Science Publishers Ltd., Feb. 2025. doi: 10.2174/0118746098346230250116065407

This is also the period where users typically escalate through the higher doses, so each increase can temporarily reset the clock

For a 3-month program, you receive three months of medication at once